Targeted mesenchymal stem cell therapy equipped with a cell-tissue nanomatchmaker attenuates osteoarthritis progression

Mesenchymal stem cells (MSCs) are at the forefront of research for a wide range of diseases, including osteoarthritis (OA). Despite having attracted the attention of orthopedists, current MSC therapy techniques are limited by poor MSC implantation in tissue defects and lack of lateral tissue integra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasiri, Nahid, Hosseini, Samaneh, Reihani-Sabet, Fakhreddin, Baghaban Eslaminejad, Mohamadreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901617/
https://www.ncbi.nlm.nih.gov/pubmed/35256711
http://dx.doi.org/10.1038/s41598-022-07969-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901617/
https://www.ncbi.nlm.nih.gov/pubmed/35256711
http://dx.doi.org/10.1038/s41598-022-07969-9

Ejemplares similares